Ocular Therapeutix (OCUL) Interest & Investment Income (2013 - 2026)
Ocular Therapeutix (OCUL) posted Interest & Investment Income of $5.45 million for Q2 2026, up 57.7% from $3.46 million a year earlier but down 9.9% from the prior quarter.
Powered by 
Analysis
Ocular Therapeutix (OCUL) Interest & Investment Income (2013 - 2026) Analysis & Trends
For the trailing twelve months through Jun 30, 2026, Interest & Investment Income at Ocular Therapeutix was $22.57 million, up 28.2% year-over-year; for FY2025, it came in at $18.36 million, down 9.5% from FY2024.
- Annual Interest & Investment Income shows a five-year compound annual growth rate of 155.7% (FY2020 to FY2025).
- In prior years, Ocular Therapeutix's Interest & Investment Income was $20.28 million in FY2024 (+409.2%), $3.98 million in FY2023 (+399.1%), $798,000 in FY2022 and $33,000 in FY2021 (-80.4%).
- Quarterly Interest & Investment Income has run from a low of $6,000 in Q4 2021 to a high of $7.34 million in Q4 2025 over five years.
- On a year-over-year basis, Interest & Investment Income has increased in each of the last three quarters, with growth averaging 85.0% over the last eight quarters.
- The strongest year-over-year quarter for Interest & Investment Income in the past five years was Q2 2023, with growth of 924.7%; the weakest was Q2 2025, with a decline of 42.8%.
- According to Business Quant data, Interest & Investment Income for the three prior quarters was $6.05 million (Q1 2026), $7.34 million (Q4 2025) and $3.73 million (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Int & Inv Inc (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 653.54 Bn | 572.07 Bn | 17.26 Bn | 219.00 Mn |
| 2 | AbbVie | 467.01 Bn | 440.17 Bn | 12.70 Bn | - |
| 3 | Merck | 367.16 Bn | 321.59 Bn | 12.21 Bn | - |
| 4 | Novartis Ag | 277.56 Bn | 233.43 Bn | 11.24 Bn | - |
| 5 | Astrazeneca | 258.23 Bn | 231.79 Bn | 12.86 Bn | 80.00 Mn |
| 6 | Amgen | 224.14 Bn | 179.54 Bn | 7.24 Bn | - |
| 7 | Gilead Sciences | 187.30 Bn | 161.42 Bn | 6.22 Bn | - |
| 8 | Pfizer | 163.47 Bn | 110.41 Bn | 10.94 Bn | - |
| 9 | Vertex Pharmaceuticals | 133.31 Bn | 105.31 Bn | 2.84 Bn | 120.60 Mn |
| 10 | Ocular Therapeutix | 2.12 Bn | 2.12 Bn | 11.46 Mn | 5.45 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 5.45 Mn |
| Mar 31, 2026 | 6.05 Mn |
| Dec 31, 2025 | 7.34 Mn |
| Sep 30, 2025 | 3.73 Mn |
| Jun 30, 2025 | 3.46 Mn |
| Mar 31, 2025 | 3.83 Mn |
| Dec 31, 2024 | 4.67 Mn |
| Sep 30, 2024 | 5.65 Mn |
| Jun 30, 2024 | 6.04 Mn |
| Mar 31, 2024 | 3.92 Mn |
| Dec 31, 2023 | 1.46 Mn |
| Sep 30, 2023 | 1.21 Mn |
| Jun 30, 2023 | 748,000.00 |
| Mar 31, 2023 | 563,000.00 |
| Dec 31, 2022 | 423,000.00 |
| Sep 30, 2022 | 285,000.00 |
| Jun 30, 2022 | 73,000.00 |
| Mar 31, 2022 | 18,000.00 |
| Dec 31, 2021 | 6,000.00 |
| Sep 30, 2021 | 7,000.00 |
API Access
Ocular Therapeutix Interest & Investment Income API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=interest-and-investment-income&ticker=OCUL&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "interest-and-investment-income", "ticker": "OCUL", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=interest-and-investment-income&ticker=OCUL&period=max&api_key=YOUR_API_KEY");
const data = await res.json();